Skip to main content
OpenTrials

Clinical trial condition

Peripheral T-cell Lymphoma

Explore clinical trials studying Peripheral T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

100 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Peripheral T-cell Lymphoma trial results

Completed

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

NCT01614197

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 32 locations
View Trial Details
Completed

Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT01796002

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • A.Z. Sint Jan AV Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • UCL Louvain Saint Luc Brussels, Belgium
View all 131 locations
View Trial Details
Completed

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT00865969

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Wilshire Oncology Medical Group, Inc La Verne, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Yale Cancer Center-Section of Medical Oncology New Haven, Connecticut, United States
View all 117 locations
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details
Completed

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

NCT02676778

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #2 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #1 Kashiwa, Chiba, Japan
  • Eisai Trial Site #1 Ōta, Gunma, Japan
View all 20 locations
View Trial Details

Related conditions